# CA2004193EN.01000101.xml

| 29.7.2004 | EN | Official Journal of the European Union | CA 193/1 |
| --- | --- | --- | --- |

29.7.2004

EN

Official Journal of the European Union

CA 193/1

---

RECRUITMENT FOR THE EUROPEAN MEDICINES AGENCY (LONDON)

RECRUITMENT FOR THE EUROPEAN MEDICINES AGENCY (LONDON)

(2004/C 193 A/01)

The Agency is responsible for coordinating the evaluation and supervision of medicinal products for human and veterinary use in the European Union (see Council Regulation (EEC) No 2309/93 of 22 July 1993,
  Official Journal of the European Communities L 214 of 24 August 1993 and Council Regulation (EC) 726/2004 of 31 March 2004,
  Official Journal of the European Union L 136 of 30 April 2004, page 1). The EMEA was established in January 1995. It has many close contacts with the European Commission, 25 EU Member States, EEA countries and many other groups in government and the private sector.

Official Journal of the European Communities

Official Journal of the European Union

Further information on the EMEA and its activities is readily accessible through the Internet; our web address is http://www.emea.eu.int

The European Medicines Agency is organising selection procedures with a view to drawing up reserve lists for:

| — | EMEA/A/186: Administrator (scientific), Unit for Veterinary Medicinal Products, Safety of Medicines (A*8), |
| --- | --- |

—

EMEA/A/186: Administrator (scientific), Unit for Veterinary Medicinal Products, Safety of Medicines (A*8),

EMEA/A/186: Administrator (scientific), Unit for Veterinary Medicinal Products, Safety of Medicines (A*8),

| — | EMEA/A/187: Administrator (scientific), Unit for Human Medicinal Products, Pre-Authorisation Evaluation, Specialised group leader in oncology (A*8), |
| --- | --- |

—

EMEA/A/187: Administrator (scientific), Unit for Human Medicinal Products, Pre-Authorisation Evaluation, Specialised group leader in oncology (A*8),

EMEA/A/187: Administrator (scientific), Unit for Human Medicinal Products, Pre-Authorisation Evaluation, Specialised group leader in oncology (A*8),

| — | EMEA/A/188: Administrator (scientific), Unit for Human Medicinal Products, Pre-Authorisation Evaluation, specialised group leader in internal medicine/central nervous system (A*8), |
| --- | --- |

—

EMEA/A/188: Administrator (scientific), Unit for Human Medicinal Products, Pre-Authorisation Evaluation, specialised group leader in internal medicine/central nervous system (A*8),

EMEA/A/188: Administrator (scientific), Unit for Human Medicinal Products, Pre-Authorisation Evaluation, specialised group leader in internal medicine/central nervous system (A*8)

| — | EMEA/A/189: Administrator (scientific), Unit for Human Medicinal Products, Pre-Authorisation Evaluation, Specialised group leader in internal medicine/diabetes/metabolic diseases (A*8), |
| --- | --- |

—

EMEA/A/189: Administrator (scientific), Unit for Human Medicinal Products, Pre-Authorisation Evaluation, Specialised group leader in internal medicine/diabetes/metabolic diseases (A*8),

EMEA/A/189: Administrator (scientific), Unit for Human Medicinal Products, Pre-Authorisation Evaluation, Specialised group leader in internal medicine/diabetes/metabolic diseases (A*8),

| — | EMEA/A/190: Administrator (scientific), Unit for Human Medicinal Products, Pre-Authorisation Evaluation, Safety and efficacy/scientific advice and orphan drugs (A*5), |
| --- | --- |

—

EMEA/A/190: Administrator (scientific), Unit for Human Medicinal Products, Pre-Authorisation Evaluation, Safety and efficacy/scientific advice and orphan drugs (A*5),

EMEA/A/190: Administrator (scientific), Unit for Human Medicinal Products, Pre-Authorisation Evaluation, Safety and efficacy/scientific advice and orphan drugs (A*5),

| — | EMEA/A/191: Administrator (scientific), Unit for Human Medicinal Products, Pre-Authorisation Evaluation, Quality of medicines (A*5), |
| --- | --- |

—

EMEA/A/191: Administrator (scientific), Unit for Human Medicinal Products, Pre-Authorisation Evaluation, Quality of medicines (A*5),

EMEA/A/191: Administrator (scientific), Unit for Human Medicinal Products, Pre-Authorisation Evaluation, Quality of medicines (A*5)

| — | EMEA/A/192: Administrator, unit for communications and networking, IT systems architect (A*5), |
| --- | --- |

—

EMEA/A/192: Administrator, unit for communications and networking, IT systems architect (A*5),

EMEA/A/192: Administrator, unit for communications and networking, IT systems architect (A*5),

| — | EMEA/B/193: Assistant, Administrative: Project Management/financial (B*3). |
| --- | --- |

—

EMEA/B/193: Assistant, Administrative: Project Management/financial (B*3).

EMEA/B/193: Assistant, Administrative: Project Management/financial (B*3).

Selected candidates will be included on a reserve list and, depending on the budgetary situation, may be offered a five-year renewable contract in accordance with the Conditions of employment of other servants of the European Communities (
  Official Journal of the European Union L 56 of 4 March 1968) (1).

Official Journal of the European Union

1

The place of employment shall be London.

Candidates must be nationals of a Member State of the European Communities, or of Iceland, Norway or Liechtenstein, on condition that they have full rights as a citizen.

The complete conditions, the job descriptions and the necessary application form should be downloaded from the EMEA website http://www.emea.eu.int. The application form must be duly signed and dated and, together with all documentary evidence, must be returned
  no later than 20 September 2004
  (date of postmark) to the following address:EMEA - Head of Personnel, 7 Westferry Circus, Canary Wharf, London E14 4HB, United Kingdom (Tel: (44-207) 418 84 00; Telefax: (44-207) 418 84 16).

The complete conditions, the job descriptions and the necessary application form should be downloaded from the EMEA website http://www.emea.eu.int. The application form must be duly signed and dated and, together with all documentary evidence, must be returned
  no later than 20 September 2004

---

(1)  The Council has adopted new Staff Regulations which entered into force on 1 May 2004. These Regulations include a new career structure. Successful candidates would therefore be recruited on the basis of the new Staff Regulations, in accordance with the arrangements set out, in particular, in Article 12 of Section 2 of Annex XIII (see the IntraComm website: http://www.europa.eu.int)

1

---